Sign In
Buy CERS
$2.66
-0.0400 (-1.48%)
At Close: Jun 03, 2026
Cerus Reports FDA Approval For INTERCEPT Blood System For Plasma With Alternate Plastic Disposable Kits
12:33pm, Monday, 04'th May 2020Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Plasma with Alternate Plastic Disposable Kits
12:30pm, Monday, 04'th May 2020
Cerus Corporation (Nasdaq:CERS) announced today FDA regulatory approval for manufacture of INTERCEPT plasma with a new, alternative plastic disposable kit. The planned conversion to these new kits is
Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Plasma with Alternate Plastic Disposable Kits
12:00am, Monday, 04'th May 2020
Cerus Corporation (Nasdaq:CERS) announced today FDA regulatory approval for manufacture of INTERCEPT plasma with a new, alternative plastic disposable
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Cramer Advises His Viewers On BP, TJX And More
12:30pm, Thursday, 30'th Apr 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer advised his viewer to be careful with BP plc (NYSE: BP). He would rather buy Chevron Corporation (NYSE: CVX).
Cerus...
Clinical trial launched testing convalescent plasma in COVID-19 patients
04:16pm, Wednesday, 29'th Apr 2020
Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have initiated a clinical trial evaluating the efficacy of convalescent plasma in COVID-19 patients.Convalescent plasma is
Moving Average Crossover Alert: Cerus
02:05pm, Wednesday, 29'th Apr 2020
Cerus Corporation (CERS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Moving Average Crossover Alert: Cerus
02:05pm, Wednesday, 29'th Apr 2020
Cerus Corporation (CERS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Cerus (NASDAQ:CERS) Upgraded at BidaskClub
06:52am, Wednesday, 29'th Apr 2020
Cerus (NASDAQ:CERS) was upgraded by research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued on Wednesday, BidAskClub reports. A number of other r
Will Cerus (CERS) Report Negative Earnings Next Week? What You Should Know
04:34pm, Tuesday, 28'th Apr 2020
Cerus (CERS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Cerus (CERS) Report Negative Earnings Next Week? What You Should Know
04:34pm, Tuesday, 28'th Apr 2020
Cerus (CERS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Forma Therapeutics Appoints David N. Cook, Ph.D., to Chief Scientific Officer
11:05am, Tuesday, 28'th Apr 2020
Forma Therapeutics announces the appointment of David N. Cook, Ph.D., to the leadership team as senior vice president and chief scientific officer
Will Cerus (CERS) Report Negative Earnings Next Week? What You Should Know
12:00am, Tuesday, 28'th Apr 2020Cerus (NASDAQ:CERS) Trading 5.5% Higher
08:56am, Sunday, 26'th Apr 2020
Shares of Cerus Co. (NASDAQ:CERS) rose 5.5% during mid-day trading on Friday . The company traded as high as $5.80 and last traded at $5.66, approximately 1,519,059 shares changed hands during mid-day
